Paradigm Capital Management Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309K Hold
5,100
0.01% 108
2025
Q4
$275K Hold
5,100
0.01% 111
2025
Q3
$230K Hold
5,100
0.01% 123
2025
Q2
$236K Sell
5,100
-5,000
-50% -$245K 0.01% 118
2025
Q1
$616K Hold
10,100
0.03% 102
2024
Q4
$571K Hold
10,100
0.03% 104
2024
Q3
$523K Hold
10,100
0.02% 112
2024
Q2
$419K Hold
10,100
0.02% 121
2024
Q1
$548K Sell
10,100
-200
-2% -$10.2K 0.03% 111
2023
Q4
$528K Hold
10,300
0.03% 114
2023
Q3
$598K Hold
10,300
0.03% 115
2023
Q2
$659K Buy
10,300
+100
+1% +$6.71K 0.04% 112
2023
Q1
$707K Hold
10,200
0.05% 111
2022
Q4
$734K Hold
10,200
0.05% 112
2022
Q3
$725K Hold
10,200
0.05% 108
2022
Q2
$785K Hold
10,200
0.05% 108
2022
Q1
$745K Hold
10,200
0.04% 116
2021
Q4
$636K Sell
10,200
-200
-2% -$11.7K 0.03% 131
2021
Q3
$615K Hold
10,400
0.03% 128
2021
Q2
$695K Hold
10,400
0.03% 132
2021
Q1
$657K Sell
10,400
-2,000
-16% -$124K 0.03% 127
2020
Q4
$769K Hold
12,400
0.05% 123
2020
Q3
$748K Hold
12,400
0.06% 115
2020
Q2
$729K Hold
12,400
0.07% 112
2020
Q1
$691K Buy
12,400
+600
+5% +$36.7K 0.08% 109
2019
Q4
$757K Buy
11,800
+1,000
+9% +$57.3K 0.06% 119
2019
Q3
$548K Buy
+10,800
New +$508K 0.05% 129

Other funds holding BMY

Paradigm Capital Management Inc's BMY Position: Q1 2026 in Review

Paradigm Capital Management Inc held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,100 shares worth $309K. The position accounts for 0.01% of the portfolio, ranked #108.

Paradigm Capital Management Inc first reported a position in BMY in Q3 2019 and has held it in 27 quarters since. The position peaked at $785K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Paradigm Capital Management Inc held 5,100 shares of Bristol-Myers Squibb worth $309K as of Q1 2026.
  • Paradigm Capital Management Inc left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.01% of Paradigm Capital Management Inc's portfolio in Q1 2026, its #108 holding.
  • Paradigm Capital Management Inc first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 27 quarters since.
  • Paradigm Capital Management Inc's Bristol-Myers Squibb position peaked at $785K in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Paradigm Capital Management Inc's 13F filing for Q1 2026, filed 14 May 2026.